Links

Tools

Export citation

Search in Google Scholar

Riluzole treatment of brain tumor initiating cells decreases expression of glucose transporter 3

Published in 2015 by Milena Ninkovic, Swetlana Sperling, Aung Thiha, Veit Rohde
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload

Abstract

Objective: Stem-like tumor cells are held responsible for tumor initiation in a variety of cancers, hence also in glioblastoma (GBM), the most lethal and prevalent primary malignant brain tumor in adults. Brain tumor initiating cells (BTICs) also display radio- and chemoresistance, which is thought [for full text, please go to the a.m. URL] ; SeriesInformation ; 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)